AUPH AURINIA PHARMACEUTICALS INC Management Changes 8-K Filing 2024 - Departure of Executive Vice President, Research and Development Aurinia Pharmaceuticals plans to terminate the employment of Dr. Volker Knappertz and provide him with a severance package.Get access to all SEC 8-K filings of the AURINIA PHARMACEUTICALS INC